Search results

|title=Sarabhai T, Koliaki C, Mastrototaro L, Kahl S, Pesta D, Apostolopoulou M, Wolkersdorfer M, Bönner AC, Bobrov P, Markgraf ...volunteers received single meals containing safflower oil (SAF), palm oil (PAL) or vehicle (VCL). Whole-body glucose metabolism was assessed from glucose

|title=Abdelwahab EMM, Pal S, Kvell K, Sarosi V, Bai P, Rue R, Krymskaya V, McPhail D, Porter A, Pongrac |authors=Abdelwahab EMM, Pal S, Kvell K, Sarosi V, Bai P, Rue R, Krymskaya V, McPhail D, Porter A, Pongrac

...e substrates. In human heart muscle addition of Oct to palmitoylcarnitine (Pal) + malate increased OXPHOS by 26% (Lemuieux et al 2011). :::+ The presence of PMG and S establishes fully operative TCA cycle activity.

...II contribution to the OXPHOS capacity, succinate was added together with Pal. In liver mitochondria, this resulted in an ∼50% smaller respiratory incr |pathways=F, S, Other combinations

...(Values around 14 to 20 (pmol/s/mg w.t.) for LEAK state and 15 to 24 (pmol/s/mg w.t.) for fatty acid triggered-OXPHOS). These data suggest either a very #Pal-C stimulated OXPHOS was recorded

:::+ The presence of PMG and S establishes a fully operative TCA cycle activity. ...derestimated. In human heart muscle addition of Oct to palmitoylcarnitine (Pal) + malate increased OXPHOS by 26% (Lemuieux et al 2011).

...[[FNS]] in [[Oxidative phosphorylation|OXPHOS state]] and of [[FNS]] and [[S]] in [[ET capacity| ET state]] can be evaluated. SUIT-015 can be extended w :::+ The presence of PMG and S establishes a fully operative TCA cycle activity.

|title=Kalia NP, Singh S, Hards K, Cheung CY, Sviriaeva E, Banaei-Esfahani A, Aebersold R, Berney M, |authors=Kalia Nitin Pal, Singh Samsher, Hards Kiel, Cheung Chen-Yi, Sviriaeva Ekaterina, Banaei-Esf

...binations in SUIT protocols, particularly: ([[N-pathway control state]], [[S-pathway control state]], [[NS-pathway control state]]). Titrations may perf :::* S: S(Rot), S, SM, ..

::::+ PM & S reconstitutes TCA cycle activity ([[PMS]]) if the 2-oxoglutarate carrier do ...ted with Oct. In human heart muscle addition of Oct to palmitoylcarnitine (Pal) & malate increased [[OXPHOS capacity| OXPHOS capacity]] by 26% ([[Lemieux_

:::+ The presence of PM and S establishes a fully operative TCA cycle activity ([[PMS]]) if the 2-oxoglut ...derestimated. In human heart muscle addition of Oct to palmitoylcarnitine (Pal) + malate increased OXPHOS by 26% (Lemuieux et al 2011).

|abbr=Pal+Oct+P+G_OXPHOS+S+Rot_ET ...ed in the [[Oxidative phosphorylation|OXPHOS state]], and [[FN]]—[[FNS]]—[[S]] in the [[ET capacity| ET state]].

|abbr=FAO(Pal) & M kinetics ...to analyse OXPHOS respiration and ET-capacity with various pathways (F, N, S, Gp)

..., Rohrbach S, Li L, Schlüter KD, Schreckenberg R, Radovits T, Oláh A, Mátyás C, Lux Á, Al-Khrasani M, Komlódi T, Bukosza N, Máthé D, Deres L, Bartek ..., Szigeti Krisztian, Hamar Peter, Helyes Zsuzsanna, Tretter Laszlo, Pacher Pal, Merkely Bela, Giricz Zoltan, Schulz Rainer, Ferdinandy Peter

|authors=Kimoloi S, Baris OR, Wiesner RJ ::::Kimoloi S(1), Baris OR(1), Wiesner RJ(1,2,3)

::::#Baris OR, Ederer S, Neuhaus JF, von Kleist-Retzow JC, Wunderlich CM, Pal M, Wunderlich FT, Peeva V, Zsurka G, Kunz WS, Hickethier T, Bunck AC, Stöc

|authors=Feichtinger RG, Vidali S, Hauser-Kronberger C, Ridzewski R, Hahn H, Kofler B ...g, Austria; 3-Inst Human Genetics, Univ Med Center, Goettingen, Germany. - s.vidali@salk.at

::::* P/M/S = [[PMS |Pyruvate&malate&succinate, PMS]], [[NS-pathway control state |NS-p ::::* S/Rot = [[Succinate pathway control state |Succinate&rotenone, SRot]], S-pathway

| A: Additivity between the N- and S-pathway in the Q-junction | A: Additivity between the N- and S-pathway in the Q-junction

::::» [[SUIT protocol]]s ...ly hyperoxic in isolated mitochondria ([[Gnaiger 2000 Proc Natl Acad Sci U S A|Gnaiger et al 2000]]), but may be hypoxic in permeabilized muscle fibers.